Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Different Pharmacological Formulations on Aspirin Resistance Reversibility in Diabetics Patients

NCT01935193 is registered in ClinicalTrials.gov with Azienda Ospedaliera San Giovanni Battista as lead sponsor.

NCT NCT01935193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01935193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Different Pharmacological Formulations on Aspirin Resistance Reversibility in Diabetics Patients
Lead sponsor
Azienda Ospedaliera San Giovanni Battista
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2011
Completion date
Not reported
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin resistance